SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 214 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14 | -58.8% | 38,853 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $34 | -99.9% | 38,853 | 0.0% | 0.01% | -50.0% |
| Q3 2022 | $61,000 | -21.8% | 38,853 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $78,000 | -14.3% | 38,853 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $91,000 | -49.7% | 38,853 | 0.0% | 0.01% | -46.2% |
| Q4 2021 | $181,000 | -38.9% | 38,853 | 0.0% | 0.03% | -43.5% |
| Q3 2021 | $296,000 | -21.3% | 38,853 | 0.0% | 0.05% | -20.7% |
| Q2 2021 | $376,000 | +17.1% | 38,853 | 0.0% | 0.06% | +11.5% |
| Q1 2021 | $321,000 | +21.1% | 38,853 | 0.0% | 0.05% | +8.3% |
| Q4 2020 | $265,000 | -38.8% | 38,853 | 0.0% | 0.05% | -51.5% |
| Q3 2020 | $433,000 | +77.5% | 38,853 | 0.0% | 0.10% | +76.8% |
| Q2 2020 | $244,000 | +243.7% | 38,853 | 0.0% | 0.06% | +180.0% |
| Q1 2020 | $71,000 | -25.3% | 38,853 | +37.9% | 0.02% | +5.3% |
| Q4 2019 | $95,000 | – | 28,170 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |